In this, and previous studies, we have used immunohistochemical detection of disease-related PrP as a means to confirm, or rule out, that an animal was clinically affected by scrapie or BSE and it should be borne in mind that our negative animals could be subclinically infected and harbour levels of prion protein below the limits of the method to detect. This evidence concerns the gene PRNP and scrapie.